• Article

Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

Bibliography

Pearson, I., Hawe, E., Zuluaga Sanchez, S., Wolowacz, S., & Haiderali, A. (2015). Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom. Value in Health, 18(7), A455. DOI: 10.1016/j.jval.2015.09.1159